Elizabeth Borden, PhD, an MD/PhD student at the University of Arizona College of Medicine – Phoenix, has been examining how the immune system impacts the neoantigen landscape in human tumors. Her findings — exploring that concept — were recently published by Immunity, a Cell Press publication.
